Collegium Pharmaceutical Unrealized Gain (Loss) on Investment Securities (Quarterly) Analysis

Collegium Pharmaceutical, Inc. (COLL)

49.31 -0.02 (-0.04%) USD | NASDAQ | Dec 19, 09:40

View Unrealized Gain (Loss) on Investment Securities (Quarterly) for COLL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Altimmune, Inc.	--
Vertex Pharmaceuticals, Inc.	--
Viking Therapeutics, Inc.	--